DashboardPortfolio'sControlelijstGemeenschapOntdekScreener
NOT FOR DISTRIBUTION
Loading...
  • Aandelen
  • /
  • Gezondheidszorg
1d geleden bijgewerkt
UFPT logo

UFP Technologies, Inc.NasdaqCM:UFPT Voorraadrapport

Marktkapitalisatie US$2.1b
1d geleden bijgewerkt
Prijs aandeel
n/a
1Y39.4%
7D-3.8%
1D0.2%
Portefeuillewaarde
​
Bekijk

UFP Technologies, Inc.

NasdaqCM:UFPT Voorraadrapport

Marktkapitalisatie: US$2.1b

  • Bedrijfsoverzicht
  • Waardering
  • Toekomstige groei
  • Prestaties in het verleden
  • Financiële gezondheid
  • Dividend
  • Beheer
  • Eigendom
  • Andere informatie
  • Aandelencommunity

UFP Technologies (UFPT) Aandelenoverzicht

UFP Technologies, Inc. ontwerpt en produceert samen met haar dochterondernemingen oplossingen voor medische hulpmiddelen, steriele verpakkingen en andere producten op maat in de Verenigde Staten. Meer informatie

UFPT fundamentele analyse
Sneeuwvlok Score
Waardering1/6
Toekomstige groei1/6
Prestaties in het verleden3/6
Financiële gezondheid5/6
Dividenden0/6

Beloningen

De winst zal naar verwachting met 12.67% per jaar groeien

De winst is de afgelopen 5 jaar met 26.1% per jaar gegroeid

Risicoanalyse

Aanzienlijke insider-verkoop in de afgelopen 3 maanden


UFPT Community Fair Values

Create Narrative

See what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
21.7% ondergewaardeerd intrinsieke korting
AnalystConsensusTarget
•1mo ago

Dominican Expansion And Refined Operations Will Spark Future Progress

113
0
3
AN
AnalystLowTarget
3.8% ondergewaardeerd intrinsieke korting
AnalystLowTarget
•1y ago

Intuitive And Stryker Dependence Will Strain Operations But Stabilize

25
0
0
AN
AnalystHighTarget
24.9% ondergewaardeerd intrinsieke korting
AnalystHighTarget
•1y ago

Aging Global Population And Nearshoring Will Fuel MedTech Demand

18
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
21.7% ondergewaardeerd intrinsieke korting
AnalystConsensusTarget
•1mo ago

Dominican Expansion And Refined Operations Will Spark Future Progress

113
0
3
AN
AnalystLowTarget
3.8% ondergewaardeerd intrinsieke korting
AnalystLowTarget
•1y ago

Intuitive And Stryker Dependence Will Strain Operations But Stabilize

25
0
0
AN
AnalystHighTarget
24.9% ondergewaardeerd intrinsieke korting
AnalystHighTarget
•1y ago

Aging Global Population And Nearshoring Will Fuel MedTech Demand

18
0
0
View all narratives

UFP Technologies, Inc. Concurrenten

Bioventus

Symbol: NasdaqGS:BVS
Market cap: US$1.1b

Merit Medical Systems

Symbol: NasdaqGS:MMSI
Market cap: US$5.2b

ICU Medical

Symbol: NasdaqGS:ICUI
Market cap: US$3.9b

Haemonetics

Symbol: NYSE:HAE
Market cap: US$4.6b

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor UFP Technologies
Historische aandelenkoersen
Huidige aandelenkoersUS$277.89
52 Week HoogtepuntUS$338.71
52 Week LaagUS$173.86
Bèta1.07
1 maand verandering-13.82%
3 maanden verandering18.28%
1 Jaar Verandering39.42%
3 jaar verandering70.02%
5 jaar verandering338.04%
Verandering sinds IPO4,732.87%

Recent nieuws en updates

Analyse-artikel • Aug 06

Earnings Beat: UFP Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

UFP Technologies, Inc. ( NASDAQ:UFPT ) defied analyst predictions to release its second-quarter results, which were...

Recent updates

Analyse-artikel • Aug 06

Earnings Beat: UFP Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

UFP Technologies, Inc. ( NASDAQ:UFPT ) defied analyst predictions to release its second-quarter results, which were...
User avatar
Narratiefupdate • Aug 04

UFPT: Record Q2 Results And Medical Focus Will Support Premium Profile

Analysts have lifted their price target for UFP Technologies from $329.50 to $355.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E that they say still support a premium valuation profile. What’s in the News for UFP Technologies UFP Technologies reported record Q2 2026 results with net sales of US$174 million, which the company described as a 15.1% increase compared with Q2 2025.
Seeking Alpha • Jul 23

UFP Technologies' Growth Prospects Are Great Enough To Necessitate An Upgrade

Summary UFP Technologies is upgraded to a soft 'Buy' due to compelling growth prospects and favorable risk-reward. UFPT targets the $518 billion global medical device market, aiming for 12%–18% annualized revenue growth via niche products and M&A. Recent Q1 results showed revenue up to $154.2 million and adjusted operating cash flow rising to $27.7 million, supporting the growth thesis. Even if UFPT only approaches its growth targets, market-beating upside remains likely, with Q2 results on the way as a near-term catalyst. Read the full article on Seeking Alpha
Analyse-artikel • Jun 22

UFP Technologies (UFPT) Stock Could Be 34.8% Below Fair Value After Recent Gains

UFP Technologies (UFPT) has attracted attention after recent trading, with the stock last closing at $239.28. For investors, the key question is how current pricing lines up with its fundamentals and recent returns. See our latest analysis for UFP Technologies. The recent 5.09% 1 day share price return at UFP Technologies adds to a 26.76% 90 day share price return, while the 5 year total shareholder return of 310.29% points to a strong longer term payoff profile. If you are comparing UFP...
Analyse-artikel • May 13

UFP Technologies, Inc. (NASDAQ:UFPT) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Investors in UFP Technologies, Inc. ( NASDAQ:UFPT ) had a good week, as its shares rose 3.8% to close at US$221...
Analyse-artikel • Feb 07

UFP Technologies' (NASDAQ:UFPT) Returns On Capital Are Heading Higher

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyse-artikel • Jan 14

Is Now The Time To Look At Buying UFP Technologies, Inc. (NASDAQ:UFPT)?

UFP Technologies, Inc. ( NASDAQ:UFPT ), might not be a large cap stock, but it received a lot of attention from a...
Analyse-artikel • Jan 01

UFP Technologies (NASDAQ:UFPT) Could Easily Take On More Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analyse-artikel • Sep 23

Should You Be Adding UFP Technologies (NASDAQ:UFPT) To Your Watchlist Today?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
User avatar
Narratiefupdate • Aug 06

Dominican Expansion And Refined Operations Will Spark Future Progress

Despite a notable decline in consensus revenue growth forecasts, the analyst price target for UFP Technologies has increased to $329.50, reflecting improved sentiment or factors offsetting lower growth expectations. What's in the News UFP Technologies was added to the Russell 2000 Dynamic Index.
Analyse-artikel • Jul 28

Investors Met With Slowing Returns on Capital At UFP Technologies (NASDAQ:UFPT)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analyse-artikel • Jul 16

Are Investors Undervaluing UFP Technologies, Inc. (NASDAQ:UFPT) By 25%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, UFP Technologies fair value estimate is US$307 Current share...
Analyse-artikel • Jul 02

UFP Technologies (NASDAQ:UFPT) Has A Pretty Healthy Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
User avatar
Nieuw narratief • May 11

Safe Patient Handling Expansion And Dominican Production Will Advance MedTech

Expansion in the safe patient handling space and Dominican operations is expected to boost revenue and margins through efficiency and shared savings.
Analyse-artikel • May 09

Results: UFP Technologies, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

UFP Technologies, Inc. ( NASDAQ:UFPT ) just released its latest first-quarter results and things are looking bullish...
Analyse-artikel • May 05

At US$202, Is It Time To Put UFP Technologies, Inc. (NASDAQ:UFPT) On Your Watch List?

UFP Technologies, Inc. ( NASDAQ:UFPT ), is not the largest company out there, but it saw significant share price...
Analyse-artikel • Mar 27

Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 49% Discount?

Key Insights The projected fair value for UFP Technologies is US$398 based on 2 Stage Free Cash Flow to Equity UFP...
Analyse-artikel • Mar 14

We Ran A Stock Scan For Earnings Growth And UFP Technologies (NASDAQ:UFPT) Passed With Ease

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analyse-artikel • Feb 13

UFP Technologies (NASDAQ:UFPT) Hasn't Managed To Accelerate Its Returns

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyse-artikel • Jan 17

UFP Technologies (NASDAQ:UFPT) Has A Pretty Healthy Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyse-artikel • Dec 31

What You Can Learn From UFP Technologies, Inc.'s (NASDAQ:UFPT) P/E After Its 26% Share Price Crash

UFP Technologies, Inc. ( NASDAQ:UFPT ) shareholders that were waiting for something to happen have been dealt a blow...
Analyse-artikel • Dec 27

Should You Think About Buying UFP Technologies, Inc. (NASDAQ:UFPT) Now?

While UFP Technologies, Inc. ( NASDAQ:UFPT ) might not have the largest market cap around , it saw significant share...
Analyse-artikel • Nov 29

Should You Be Adding UFP Technologies (NASDAQ:UFPT) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analyse-artikel • Nov 08

Results: UFP Technologies, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

UFP Technologies, Inc. ( NASDAQ:UFPT ) investors will be delighted, with the company turning in some strong numbers...
Analyse-artikel • Oct 29

Returns On Capital Are Showing Encouraging Signs At UFP Technologies (NASDAQ:UFPT)

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analyse-artikel • Oct 16

Here's Why UFP Technologies (NASDAQ:UFPT) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyse-artikel • Oct 03

Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 43% Discount?

Key Insights The projected fair value for UFP Technologies is US$538 based on 2 Stage Free Cash Flow to Equity Current...
Analyse-artikel • Sep 19

What Is UFP Technologies, Inc.'s (NASDAQ:UFPT) Share Price Doing?

UFP Technologies, Inc. ( NASDAQ:UFPT ), is not the largest company out there, but it received a lot of attention from a...
Analyse-artikel • Aug 03

UFP Technologies, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

A week ago, UFP Technologies, Inc. ( NASDAQ:UFPT ) came out with a strong set of quarterly numbers that could...
Analyse-artikel • Jul 17

There's Reason For Concern Over UFP Technologies, Inc.'s (NASDAQ:UFPT) Massive 27% Price Jump

UFP Technologies, Inc. ( NASDAQ:UFPT ) shares have continued their recent momentum with a 27% gain in the last month...
Analyse-artikel • Jul 12

The Return Trends At UFP Technologies (NASDAQ:UFPT) Look Promising

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Seeking Alpha • Jul 02

UFP Technologies: Impressive Has Become Expensive

Summary UFP Technologies, Inc. has long been somewhat of a hidden gem, active in the manufacturing of custom medical components. The company acquires AJR Enterprises at a substantial discount, boosting sales and earnings growth potential. Valuation multiples have steadily increased over time, with shares trading at a premium in terms of earnings multiples. With UFP Technologies trading at fresh highs, I fail to see the appeal as expectations have risen considerably, but the company definitely deserves a spot on my watch list. Read the full article on Seeking Alpha
Analyse-artikel • Jun 22

Is UFP Technologies (NASDAQ:UFPT) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analyse-artikel • May 30

Unpleasant Surprises Could Be In Store For UFP Technologies, Inc.'s (NASDAQ:UFPT) Shares

UFP Technologies, Inc.'s ( NASDAQ:UFPT ) price-to-earnings (or "P/E") ratio of 42.1x might make it look like a strong...
Analyse-artikel • Apr 11

Should You Be Adding UFP Technologies (NASDAQ:UFPT) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Rendement voor aandeelhouders

UFPTUS Medical EquipmentUS Markt
7D-3.8%-5.8%-2.2%
1Y39.4%-19.9%13.1%

Rendement versus industrie: UFPT overtrof de US Medical Equipment industrie, die het afgelopen jaar een rendement -19.9 % opleverde.

Rendement versus markt: UFPT overtrof de US markt, die het afgelopen jaar een rendement opleverde van 13.1 %.

Prijsvolatiliteit

Is UFPT's price volatile compared to industry and market?
UFPT volatility
UFPT Average Weekly Movement9.1%
Medical Equipment Industry Average Movement8.3%
Market Average Movement6.9%
10% most volatile stocks in US Market15.4%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: UFPT heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 9% ) van UFPT is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19634,846Mitchell Rockwww.ufpt.com

UFP Technologies, Inc. ontwerpt en produceert samen met haar dochterondernemingen oplossingen voor medische apparatuur, steriele verpakkingen en andere producten op maat in de Verenigde Staten. Het bedrijf levert beschermende afdekdoeken voor robotchirurgie, behandeling en comfort van patiënten, geavanceerde wondverzorging, infectiepreventie, disposables voor chirurgische en endoscopische procedures, verpakkingen voor medische apparaten, orthopedische implantaten, componenten voor hartimplantaten, dispenserspoelen voor katheters en biofarmaceutische medicijnproductie. Het bedrijf biedt ook materiaalbescherming en verpakkingen voor vuurwapens, onbemande luchtvaartuigen/drones, wapensystemen, elektronische apparaten, communicatieapparatuur en gereedschappen en reparatiekits; kussen- en beschermende verpakkingen; akoestische en thermische isolatiecomponenten voor de auto-industrie, lucht- en ruimtevaart, consumenten en de industrie; filtratie voor kleine motoren, airconditioners, luchtbevochtigers, koelkasten, elektronische luchtreinigers, geforceerde luchttoestellen en industriële compressoren; vloeistofmanagement; en afdichtingen en pakkingen voor de auto-industrie, chemische verwerking, bouw- en constructietoepassingen.

UFP Technologies, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van UFP Technologies zich tot de beurswaarde?
UFPT fundamentele statistieken
MarktkapitalisatieUS$2.15b
Inkomsten(TTM)US$72.30m
Inkomsten(TTM)US$631.64m
29.8x
Koers/Winstverhouding
3.4x
P/S-verhouding

Is UFPT overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
UFPT resultatenrekening (TTM)
InkomstenUS$631.64m
Kosten van inkomstenUS$451.64m
BrutowinstUS$180.00m
Overige uitgavenUS$107.70m
InkomstenUS$72.30m

Laatst gerapporteerde inkomsten

Jun 30, 2026

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)9.33
Brutomarge28.50%
Nettowinstmarge11.45%
Schuld/Eigen Vermogen Verhouding25.4%

Hoe presteerde UFPT op de lange termijn?

Bekijk historische prestaties en vergelijking

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/11 00:55
Aandelenkoers aan het einde van de dag2026/09/11 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
  • SEC-formulier 10-K
  • SEC-formulier 10-Q
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
  • Onderzoeksrapporten van analisten
  • Blue Matrix
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
  • ICE Marktgegevens
  • SEC-formulier S-1
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
  • SEC-formulier 4
  • SEC-formulier 13D
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
  • SEC-formulier 10-K
  • SEC-formulier DEF 14A
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen
  • SEC-formulier 8-K

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

UFP Technologies, Inc. wordt gevolgd door 7 analisten. 4 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Jonathan TanwantengCJS Securities, Inc.
Justin AgesCJS Securities, Inc.
Brett FishbinKeyBanc Capital Markets Inc.

Neem overal betere beleggingsbeslissingen

Scan om te downloaden
Open App StoreGoogle Play openen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Gegevensbronnen bekijken
Markten
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Beleggingsideeën
  • Ondergewaardeerde bedrijven
  • Dividendkrachtpatsers
  • Kopen met voorkennis
  • Kernenergie
  • Autonome voertuigen
  • Kunstmatige intelligentie
  • Crypto en blockchain
  • Cyberbeveiliging
  • Meer ideeën
Voorraad Gemeenschappen
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Functies en gereedschappen
  • Portfolio Volger
  • Aandelen screener & waarschuwingen
  • Diverse en eerlijke waarden
  • Dividend berekenen
Nieuws & Ontdekkingen
  • Laatste voorraadnieuws
  • Globale markt Inzichten
  • De Foxhole
  • Beleggingsideeën
  • Community nominale waarden
  • Nieuw
Simply Wall St
  • Plannen en prijzen
  • Adverteren
  • Over ons
  • Neem contact met ons op
  • Carrière
  • Helpcentrum
  • Leren beleggen in aandelen
  • Affiliate programma
  • Bedrijf & Onderneming
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Algemene voorwaarden
  • Privacybeleid
  • AI-voorwaarden
  • Gids voor financiële diensten